ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56dimCD16+ and CD56brightCD16dim/− natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients
Crossref DOI link: https://doi.org/10.1186/s12967-016-0859-z
Published Online: 2016-04-21
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Huth, Teilah Kathryn
Staines, Donald
Marshall-Gradisnik, Sonya
Funding for this research was provided by:
Judith Jane Mason and Harold Stannett Williams Memorial Foundation
Alison Hunter Memorial Foundation
Stafford Fox Medical Research Foundation
Queensland Government
